Get In Touch

Coronary heart disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism are the major cardiovascular diseases affecting millions of people globally. Incidence of cardiovascular diseases has increased significantly, especially in Asia Pacific. Prevalence of cardiovascular diseases is higher in countries in the West including the U.S., the U.K., Germany, France, and Russia. Bioresorbable vascular scaffolds such as poly-L-lactide (PLLA) bioresorbable scaffold, metallic bioresorbable scaffolds, and hybrid bioresorbable scaffold help patients suffering from different types of cardiovascular diseases. The number of patients suffering from cardiovascular diseases admitted to hospital inpatient and outpatient settings has increased markedly. A shift from usage of conventional metallic stents to bioresorbable vascular scaffolds has been observed for the treatment of CVDs.

Increasing prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is a major factor driving the bioresorbable vascular scaffold market. Other factors anticipated to drive the market include preference for drug-eluting devices for angioplasty, increasing number of domestic and global players entering the market with new products and techniques, leading to increase in funding for R&D of surgical procedures using stents for treating stroke and other cardiovascular diseases. However, preference for vascular graft devices for angioplasty and coronary artery diseases leading to a rise in outpatient treatment of cardiovascular diseases is projected to restrain the market during the forecast period.

The global bioresorbable vascular scaffold market can be segmented based on product type, disease indication, end-user, and region. In terms of product type, the market can be categorized into masks, tubes, inhalers, and others. Based on disease indication, the global bioresorbable vascular scaffold market can be classified into coronary artery disease, pulmonary artery disease, and other vascular diseases. The coronary artery disease segment is projected to account for a large share of the global bioresorbable vascular scaffold market during the forecast period due to increasing prevalence of ischemic heart disease and rising demand for by-pass surgery procedures, especially in emerging economies such as China, Brazil, the UAE, and India. In terms of end-user, the market can be segmented into hospitals, surgery clinics, ambulatory care centers, and others.

In terms of region, the global bioresorbable vascular scaffold market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period. According to the Centers for Disease Control and Prevention, heart disease accounts for around 610,000 deaths in the U.S. each year. Coronary heart disease (CHD) is the most common type of heart disease and accounts for over 370,000 deaths annually. Furthermore, increasing prevalence of cardiovascular diseases such as coronary heart disease and rising number of cardiovascular surgeries due to obesity and fatigue among young population because of unhealthy food habits especially in developing countries such as China, Australia, and India are likely to propel the bioresorbable vascular scaffold market in Asia Pacific. Moreover, WHO statistics stated that cardiovascular diseases accounted for an estimated 17.7 million deaths in 2015; around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. However, incidence of coronary heart disease, peripheral arterial disease, and other cardiovascular diseases is rising in Asia Pacific due to increase in smoking, unhealthy food habits, and a large geriatric patient population. This, in turn, is anticipated to fuel demand for cost-effective bioresorbable vascular scaffold devices. These factors are projected to drive the bioresorbable vascular scaffold market in Asia Pacific between 2017 and 2025.

Key players operating in the global bioresorbable vascular scaffold market include Abbott, Cook Medical, Boston Scientific Corporation, W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), B. Braun Melsungen AG, and Terumo Corporation among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Bioresorbable Vascular Scaffold Market